IMPAQ Strategy Expands to International Markets Through ASCEND Health Data Capture™

Columbia, Maryland - ASCEND Health Data Capture™ (HDC), a component of the ASCEND Health Intelligence Platform™, is now supporting international healthcare research studies including patient-reported outcomes in 70 countries.

This platform uses patient-friendly design and technology to easily and quickly capture patient-reported outcomes either within healthcare environments, or in the home. The platform delivers tools that are designed for mobile devices including smartphones and tablets, and desktop computers. Additionally, ASCEND HDC automatically captures informed consent agreements from patients, and can also manage and deliver reminders and incentives for patient participation.

“We are excited to further expand the market of our ASCEND HDC”, said  Job De Bruyne, Director of Product Management. “The flexibility of our product allows us to support research studies of all scales across the globe and we are focused on continuing to deliver customizable, user-friendly data collection solutions to our customers.”  

The HDC platform incorporates the product assets and software-based contracts that have been acquired from Digital Support B.V., a Europe-based healthcare technology firm. IMPAQ Strategy is rapidly expanding the customer base for this platform to support patient reported outcomes with new and existing national and international patient registries.

IMPAQ Strategy is a division of IMPAQ International LLC, a research and analytics company spanning markets of health, labor, human services, education and international development.